May 24, 2012 – While industry awaits the final regulations to implement the Physician Payment Sunshine Act it can gain a better understanding of the Act’s implications at a June 27 Drug Information Association Annual Meeting session moderated by Coalition for Healthcare Communication Executive Director John Kamp.

During this session, expert panelists will discuss the Sunshine Act regulations’ likely impact – both burdens and benefits – on public health and relevant stakeholders, including government, lawyers, accountants, pharmaceutical and medical device companies, researchers, investigators, physicians and others.

DIA session attendees will hear from the following panelists, in addition to Kamp:
John J. Lewis, MA
Vice President, Public Affairs
Association of Clinical Research Organizations

Thomas P. Stossel, MD
Director, Translational Medicine Unit and Center for

Medical Innovation
Brigham & Women”s Hospital

Sandra J P Dennis, JD
Deputy General 50mg viagra Counsel
Biotechnology Industry Organization (BIO)

Daniel Carlat, MD
Director
Pew Prescription Project

Marjorie E. Powell, JD
Senior Assistant General Counsel
PhRMA

The DIA annual meeting will be held June 24-28 in Philadelphia. To register, go to: diahome.org/dia2012. Coalition Web site readers will receive a 10% discount on their registration by entering DIA2012SP.